Strategic partnerships Obatala Sciences offers contract research services and research products to pharma, government, CROs, non-profits, and academic labs, presenting opportunities to co-develop adipose tissue models like ObaCell for obesity, diabetes, and metabolism programs.

ObaCell advantage ObaCell Obesity-on-a-Chip provides a holistic human adipose tissue model for disease modeling and drug screening, enabling potential partners to de-risk early-stage compounds with in vitro human-relevant data.

Growth indicators Recent awards and product launches, including Small Business of the Year and ObaCell service introduction, signal market validation and readiness for expanded client engagements and longer-term contracts.

Financing signals Current revenue range and growing funding profile suggest capacity to scale collaborations, pilot projects, and larger multi-year contracts with pharmaceutical and biotech customers.

Target extensions Diverse application areas such as proteomics, genomics, adipokine secretion, and white/brown fat tissue formation create cross-sell opportunities across metabolics, wound healing, and musculoskeletal research pipelines.